- Market Realist•3 hours ago
GlaxoSmithKline’s (GSK) Pharmaceuticals segment revenues have declined substantially in 2015 due to the divestment of its Oncology business to Novartis (NVS) in March 2015.
- Market Realist•4 hours ago
Analysts expect ~16.5% growth in GlaxoSmithKline’s (GSK) 1Q17 revenues to ~7.3 billion pounds following strong product launches, acquired products from Novartis (NVS), and improvement in the supply chain....
- Market Realist•6 hours ago
GlaxoSmithKline is set to release its 1Q17 earnings on April 26, 2017. Analysts estimate GSK's earnings per share to reach 0.25 pounds for 1Q17.
GSK.L : Summary for GLAXOSMITHKLINE PLC ORD 25P - Yahoo Finance
GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
|Bid||1,553.00 x 175400|
|Ask||1,605.00 x 417900|
|Day's Range||1,580.00 - 1,602.00|
|52 Week Range||1,363.00 - 1,745.56|
|PE Ratio (TTM)||85.97|
|Dividend & Yield||1.01 (4.94%)|
|1y Target Est||N/A|